The novel approach of the medication represents a significant development in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide820550.ka-blogs.com/95552565/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment